The
#SARSCoV2
virus is accumulating mutations with amino acid substitutions faster than other endemic viruses, including 2.5 fold more rapidly than influenza (A/H3N2 HA1), the prototype of rapid antigen evolution
@cellhostmicrobe
@tvrb
@fredhutch
生後6カ月以上の対象者に無料で新型コロナワクチンの接種を受けることができる期間は今月末まで。
来年度の4月以降は、高齢者の方には定期接種のB類での接種(自己負担7000円程度)、それ以外は補助なしでの自費接種となります。
Free COVID-19 vaccinations are available until the end of this month
Our paper on JN.1 is now online
@TheLancetInfDis
!
The manuscript explains how a single RBD mutation L455S could turn BA.2.86 into a heavy immune evasive variant JN.1.
Notably, JN.1 is now approaching worldwide dominance (42% two weeks ago).
The WHO Technical Advisory Group on
#COVID19
Vaccine Composition recommends that the next formulations use a monovalent JN.1 lineage. The FDA Vaccines Advisory Committee will meet on May 16 to make recommendations for 2024-25 COVID vaccines via
@CIDRAP
NYC is seeing their Pirola spike I think. JN.1 dominance was about a week ago, hospitalizations up 36% since then.
Last winter they were about double the current levels in hospital, but only increasing 5%/wk.